Literature DB >> 20463408

Mitochondria dysfunction and neurodegenerative disorders: cause or consequence.

Vanessa A Morais1, Bart De Strooper.   

Abstract

Mitochondria are crucial regulators of energy metabolism and apoptotic pathways and have been closely linked to the pathogenesis of neurodegenerative disorders. In this review we mainly focus on mitochondrial dysfunction in two of the most prevalent neurological disorders: Alzheimer's disease and Parkinson's disease. We discuss whether the role of mitochondria in those diseases should be considered primordial or secondary to other processes that eventually lead to neurodegeneration. In the case of Parkinson's disease, the role of mitochondria is quite clear and might be involved in the mechanism of this disorder. For Alzheimer's disease, the evidence in favor of such a link is more indirect, and mitochondrial dysfunction likely occurs at a later stage of the disorder.

Entities:  

Mesh:

Year:  2010        PMID: 20463408     DOI: 10.3233/JAD-2010-100345

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  40 in total

1.  PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.

Authors:  Bin Zheng; Zhixiang Liao; Joseph J Locascio; Kristen A Lesniak; Sarah S Roderick; Marla L Watt; Aron C Eklund; Yanli Zhang-James; Peter D Kim; Michael A Hauser; Edna Grünblatt; Linda B Moran; Silvia A Mandel; Peter Riederer; Renee M Miller; Howard J Federoff; Ullrich Wüllner; Spyridon Papapetropoulos; Moussa B Youdim; Ippolita Cantuti-Castelvetri; Anne B Young; Jeffery M Vance; Richard L Davis; John C Hedreen; Charles H Adler; Thomas G Beach; Manuel B Graeber; Frank A Middleton; Jean-Christophe Rochet; Clemens R Scherzer
Journal:  Sci Transl Med       Date:  2010-10-06       Impact factor: 17.956

2.  Acetate supplementation attenuates lipopolysaccharide-induced neuroinflammation.

Authors:  Chris J Reisenauer; Dhaval P Bhatt; Dane J Mitteness; Evan R Slanczka; Heidi M Gienger; John A Watt; Thad A Rosenberger
Journal:  J Neurochem       Date:  2011-02-24       Impact factor: 5.372

Review 3.  Cell signaling and mitochondrial dynamics: Implications for neuronal function and neurodegenerative disease.

Authors:  Theodore J Wilson; Andrew M Slupe; Stefan Strack
Journal:  Neurobiol Dis       Date:  2012-01-24       Impact factor: 5.996

4.  Functional genomic analyses identify pathways dysregulated by progranulin deficiency, implicating Wnt signaling.

Authors:  Ezra Y Rosen; Eric M Wexler; Revital Versano; Giovanni Coppola; Fuying Gao; Kellen D Winden; Michael C Oldham; Lauren Herl Martens; Ping Zhou; Robert V Farese; Daniel H Geschwind
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

5.  PGC-1α overexpression exacerbates β-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease.

Authors:  Magali Dumont; Cliona Stack; Ceyhan Elipenahli; Shari Jainuddin; Nathalie Launay; Meri Gerges; Natalia Starkova; Anatoly A Starkov; Noel Y Calingasan; Davide Tampellini; Aurora Pujol; M Flint Beal
Journal:  FASEB J       Date:  2014-01-07       Impact factor: 5.191

6.  Exposure to Mn/Zn ethylene-bis-dithiocarbamate and glyphosate pesticides leads to neurodegeneration in Caenorhabditis elegans.

Authors:  Rekek Negga; David A Rudd; Nathan S Davis; Amanda N Justice; Holly E Hatfield; Ana L Valente; Anthony S Fields; Vanessa A Fitsanakis
Journal:  Neurotoxicology       Date:  2011-03-03       Impact factor: 4.294

7.  Close encounter: mitochondria, endoplasmic reticulum and Alzheimer's disease.

Authors:  Bart De Strooper; Luca Scorrano
Journal:  EMBO J       Date:  2012-10-09       Impact factor: 11.598

Review 8.  Mitochondrial dynamics in the central regulation of metabolism.

Authors:  Carole M Nasrallah; Tamas L Horvath
Journal:  Nat Rev Endocrinol       Date:  2014-09-09       Impact factor: 43.330

9.  Acetate supplementation increases brain phosphocreatine and reduces AMP levels with no effect on mitochondrial biogenesis.

Authors:  Dhaval P Bhatt; Heidi M Houdek; John A Watt; Thad A Rosenberger
Journal:  Neurochem Int       Date:  2013-01-12       Impact factor: 3.921

Review 10.  Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases.

Authors:  Epiphani C Simmons; Natalie E Scholpa; Rick G Schnellmann
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.